ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase II Trial of Weekly Docetaxel/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer
Clinical Breast Cancer
◽
10.3816/cbc.2006.n.003
◽
2006
◽
Vol 6
(6)
◽
pp. 505-510
◽
Cited By ~ 15
Author(s):
Joyce A. O'Shaughnessy
◽
Robert Pluenneke
◽
Jack Sternberg
◽
Pankaj Khandelwal
◽
Des Ilegbodu
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
Weekly Docetaxel
◽
Locally Recurrent
◽
Line Chemotherapy
Download Full-text
Related Documents
Cited By
References
First-line chemotherapy of advanced or metastatic breast cancer (MBC) with docetaxel and doxorubicin in Indonesia: results from A phase II trial
Medical Journal of Indonesia
◽
10.13181/mji.v14i1.166
◽
2005
◽
pp. 20
Author(s):
Abdulmuthalib Abdulmuthalib
◽
Idral Darwis
◽
Nugroho Prayogo
◽
Sutjipto Sutjipto
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
Line Chemotherapy
Download Full-text
Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer
Clinical Breast Cancer
◽
10.1016/j.clbc.2013.02.008
◽
2013
◽
Vol 13
(4)
◽
pp. 239-246.e1
◽
Cited By ~ 19
Author(s):
Andrew D. Seidman
◽
Alison K. Conlin
◽
Ariadne Bach
◽
Mary Ellen Moynahan
◽
Diana Lake
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
Randomized Phase Ii
◽
Line Chemotherapy
Download Full-text
Phase II Trial of Nab-Paclitaxel Compared With Docetaxel as First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Final Analysis of Overall Survival
Clinical Breast Cancer
◽
10.1016/j.clbc.2012.05.001
◽
2012
◽
Vol 12
(5)
◽
pp. 313-321
◽
Cited By ~ 71
Author(s):
William J. Gradishar
◽
Dimitry Krasnojon
◽
Sergey Cheporov
◽
Anatoly N. Makhson
◽
Georgiy M. Manikhas
◽
...
Keyword(s):
Breast Cancer
◽
Overall Survival
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
Final Analysis
◽
First Line
◽
Line Chemotherapy
Download Full-text
North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
Annals of Oncology
◽
10.1093/annonc/mdp512
◽
2010
◽
Vol 21
(2)
◽
pp. 269-274
◽
Cited By ~ 23
Author(s):
E.A. Perez
◽
D.W. Hillman
◽
T. Dentchev
◽
N.A. Le-Lindqwister
◽
L.H. Geeraerts
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
North Central
◽
Line Chemotherapy
Download Full-text
Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients (pts) with HER2-positive metastatic breast cancer (MBC)
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.1032
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 1032-1032
◽
Cited By ~ 2
Author(s):
N. W. Peacock
◽
J. R. Infante
◽
D. A. Yardley
◽
H. A. Burris
◽
F. A. Greco
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
Her2 Positive
◽
Weekly Docetaxel
◽
First Line Treatment
Download Full-text
Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer
Clinical Breast Cancer
◽
10.3816/cbc.2009.n.004
◽
2009
◽
Vol 9
(1)
◽
pp. 23-28
◽
Cited By ~ 17
Author(s):
Jeffrey R. Infante
◽
Denise A. Yardley
◽
Howard A. Burris
◽
F. Anthony Greco
◽
Cindy P. Farley
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
Her2 Positive
◽
Weekly Docetaxel
◽
First Line Treatment
Download Full-text
Anti-hormonal maintenance treatment with or without the CDK4/6 inhibitor ribociclib after first line chemotherapy in hormone receptor positive/HER2 negative metastatic breast cancer: A phase II trial (AMICA) GBG 97
Annals of Oncology
◽
10.1093/annonc/mdy272.352
◽
2018
◽
Vol 29
◽
pp. viii119
Author(s):
T. Decker
◽
C. Denkert
◽
K. Lübbe
◽
V. Müller
◽
C. Mundhenke
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Hormone Receptor
◽
Maintenance Treatment
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
Hormone Receptor Positive
◽
Line Chemotherapy
Download Full-text
Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer
British Journal of Cancer
◽
10.1038/sj.bjc.6601518
◽
2004
◽
Vol 90
(1)
◽
pp. 31-35
◽
Cited By ~ 22
Author(s):
F Cappuzzo
◽
F Mazzoni
◽
A Gennari
◽
S Donati
◽
B Salvadori
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
Line Chemotherapy
Download Full-text
A Phase II Trial of Docetaxel and Carboplatin as First-Line Chemotherapy for Metastatic Breast Cancer: NCCTG Study N9932
Oncology
◽
10.1159/000087813
◽
2005
◽
Vol 69
(2)
◽
pp. 117-121
◽
Cited By ~ 10
Author(s):
Edith A. Perez
◽
Vera J. Suman
◽
Tom R. Fitch
◽
James A. Mailliard
◽
James N. Ingle
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
Line Chemotherapy
Download Full-text
Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial
European Journal of Cancer
◽
10.1016/j.ejca.2003.08.013
◽
2004
◽
Vol 40
(3)
◽
pp. 352-357
◽
Cited By ~ 46
Author(s):
A.J ten Tije
◽
C.H Smorenburg
◽
C Seynaeve
◽
A Sparreboom
◽
K.L.C Schothorst
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Elderly Patients
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
Weekly Paclitaxel
◽
First Line
◽
Multicentre Phase
◽
Line Chemotherapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close